Teruya S - Search Results

1

Mosaic Loss of the Y Chromosome Is Enriched in Patients With Wild-Type Transthyretin Cardiac Amyloidosis and Associated With Increased Mortality.

Thel MC, Cochran JD, Teruya S, Hayashi O, Xie CR, Srinivasan AR, Chavkin NW, Arai Y, Sano S, Mirabal Santos A, De Los Santos J, Fine D, Sabogal N, Ullah I, Helmke S, Rodriguez C, Prokaeva T, Foster RH, Spencer BH, Izumiya Y, Maurer MS, Walsh K, Ruberg FL. Thel MC, et al. Among authors: teruya s. Circ Heart Fail. 2024 Aug;17(8):e011681. doi: 10.1161/CIRCHEARTFAILURE.124.011681. Epub 2024 Jun 10. Circ Heart Fail. 2024. PMID: 38853760 No abstract available.

2

Linkage analysis of the genetic determinants of high density lipoprotein concentrations and composition: evidence for involvement of the apolipoprotein A-II and cholesteryl ester transfer protein loci.

Bu X, Warden CH, Xia YR, De Meester C, Puppione DL, Teruya S, Lokensgard B, Daneshmand S, Brown J, Gray RJ, et al. Bu X, et al. Among authors: teruya s. Hum Genet. 1994 Jun;93(6):639-48. doi: 10.1007/BF00201563. Hum Genet. 1994. PMID: 8005588

3

Peak cardiac power measured noninvasively with a bioreactance technique is a predictor of adverse outcomes in patients with advanced heart failure.

Rosenblum H, Helmke S, Williams P, Teruya S, Jones M, Burkhoff D, Mancini D, Maurer MS. Rosenblum H, et al. Among authors: teruya s. Congest Heart Fail. 2010 Nov-Dec;16(6):254-8. doi: 10.1111/j.1751-7133.2010.00187.x. Epub 2010 Oct 19. Congest Heart Fail. 2010. PMID: 21091609 Free PMC article.

4

Blood volume measurements in patients with heart failure and a preserved ejection fraction: implications for diagnosing anemia.

Noumi B, Teruya S, Salomon S, Helmke S, Maurer MS. Noumi B, et al. Among authors: teruya s. Congest Heart Fail. 2011 Jan-Feb;17(1):14-8. doi: 10.1111/j.1751-7133.2010.00208.x. Epub 2011 Jan 24. Congest Heart Fail. 2011. PMID: 21272222 Free PMC article.

5

A dosing algorithm for erythropoietin alpha in older adults with heart failure and a preserved ejection fraction.

Altincatal A, Macarthur RB, Teruya S, Helmke S, Maurer MS. Altincatal A, et al. Among authors: teruya s. Cardiovasc Ther. 2013 Apr;31(2):92-9. doi: 10.1111/j.1755-5922.2011.00295.x. Epub 2011 Aug 26. Cardiovasc Ther. 2013. PMID: 21884028 Free PMC article. Clinical Trial.

6

Treating anemia in older adults with heart failure with a preserved ejection fraction with epoetin alfa: single-blind randomized clinical trial of safety and efficacy.

Maurer MS, Teruya S, Chakraborty B, Helmke S, Mancini D. Maurer MS, et al. Among authors: teruya s. Circ Heart Fail. 2013 Mar;6(2):254-63. doi: 10.1161/CIRCHEARTFAILURE.112.969717. Epub 2012 Dec 20. Circ Heart Fail. 2013. PMID: 23258574 Free PMC article. Clinical Trial.

7

Impact of epoetin alfa on left ventricular structure, function, and pressure volume relations as assessed by cardiac magnetic resonance: the heart failure preserved ejection fraction (HFPEF) anemia trial.

Green P, Babu BA, Teruya S, Helmke S, Prince M, Maurer MS. Green P, et al. Among authors: teruya s. Congest Heart Fail. 2013 Jul-Aug;19(4):172-9. doi: 10.1111/chf.12027. Epub 2013 Mar 20. Congest Heart Fail. 2013. PMID: 23517485 Free PMC article. Clinical Trial.

8

Differences in blood volume components between hyporesponders and responders to erythropoietin alfa: the heart failure with preserved ejection fraction (HFPEF) anemia trial.

Borovka M, Teruya S, Alvarez J, Helmke S, Maurer MS. Borovka M, et al. Among authors: teruya s. J Card Fail. 2013 Oct;19(10):685-91. doi: 10.1016/j.cardfail.2013.08.508. J Card Fail. 2013. PMID: 24125107 Free PMC article. Clinical Trial.

9

Cardiovascular effects of hemoglobin response in patients receiving epoetin alfa and oral iron in heart failure with a preserved ejection fraction.

Vullaganti S, Goldsmith J, Teruya S, Alvarez J, Helmke S, Maurer MS. Vullaganti S, et al. Among authors: teruya s. J Geriatr Cardiol. 2014 Jun;11(2):100-5. doi: 10.3969/j.issn.1671-5411.2014.02.002. J Geriatr Cardiol. 2014. PMID: 25009558 Free PMC article.

10

The myocardial contraction fraction is superior to ejection fraction in predicting survival in patients with AL cardiac amyloidosis.

Tendler A, Helmke S, Teruya S, Alvarez J, Maurer MS. Tendler A, et al. Among authors: teruya s. Amyloid. 2015 Mar;22(1):61-6. doi: 10.3109/13506129.2014.994202. Epub 2014 Dec 16. Amyloid. 2015. PMID: 25510353

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

94 results

Search Page

Filters